QIAGEN/Digene Merger Granted US Antitrust Approval

Includes: DIGE, QGEN

QIAGEN (NASDAQ:QGEN) and Digene (DIGE) announced on Tuesday that the 30 day waiting period required under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 expired on July 16 without any action taken by the United States government to delay the deal.

Antitrust approval is one of the conditions to completing the transaction.

The merger is also dependent on the tender of of a majority of Digene's outstanding shares in a tender offer that ends on July 20.

The companies also stated that they expect the merger, which was announced on June 3, to be completed in August or September.

Shareholders will receive $61.25 per share in cash or stock upon completion of the merger.

About this article:

Problem with this article? Please tell us. Disagree with this article? .